Abstract
Background/Aim: ZO-1 is a good marker for tight junction integrity which may be damaged in many intestinal diseases. ZO-1 can also accumulate in the cellular nucleus in addition to sites of cell-cell contact, suggesting a potential role in cellular proliferation and differentiation. We evaluated the expression and distribution of ZO-1 in patients with celiac disease before and after a gluten-free diet. Methods: The ZO-1 expression was evaluated semiquantitatively by means of immunohistochemical analysis in duodenal bioptic specimens of 10 consecutive patients with celiac disease before and after a gluten-free diet and in 10 controls. Furthermore, the nuclear staining was analyzed quantitatively, evaluating 3,000 cells for each count, and it was expressed as a percentage of labeled nuclei over the total of analyzed cells. Results: The intestinal mucosa of untreated celiac disease patients shows a globally lower ZO-1 labeling than that of controls. The expression of ZO-1 in the treated celiac mucosa did not differ significantly from normal intestinal mucosa of healthy subjects. At the crypt level of untreated celiac mucosa, a low intensity of nuclear labeling (1.75 ± 0.32%) was found, while in both treated celiac disease patients and in normal subjects we observed a statistically significant higher percentage of strongly labeled nuclei (53.72 ± 6.30% and 56.79 ± 5.45%, respectively; p = 0.0002). Conclusions: Our data show a global underexpression of ZO-1 in the duodenal mucosa of active celiac disease patients. Gluten withdrawal allows a normalization of the ZO-1 expression in treated celiac disease patients. Furthermore, the particular pattern of ZO-1 resembles the cellular distribution in undifferentiated cells and may be the result of immaturity of the enterocytes in untreated celiac sprue.
Journal Section:
Original Paper: Intestinal Disorders
References
1.
Hollander D: The intestinal permeability barrier: A hypothesis as to its regulation and involvement in Crohn’s disease. Scand J Gastroenterol 1992;27:721–726.
[PubMed]
2.
Balda MS, Matter K: Tight junctions. J Cell Sci 1998;111:541–547.
[PubMed]
3.
Lapierre LA: The molecular structure of the tight junction. Adv Drug Deliv Rev 2000;41:255–264.
[PubMed]
4.
Marin ML, Greenstein AJ, Geller SA, Gordon RE, Afuses AH Jr: A freeze fracture study of Crohn’s disease of the terminal ileum: Changes in epithelial tight junction organization. Am J Gastroenterol 1983;78:537–547.
[PubMed]
5.
Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M: Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 1998;43(4 Pt 1):435–441.
6.
Caselli M, Ruina M, La Corte R, Trevisani L, Sartori S, Dentale A, Gaudenzi P, Trotta F, Alvisi V: Ultrastructural damage of gastric epithelium in patients taking NSAIDs. Ital J Gastroenterol 1996;28(suppl 4):16–18.
7.
Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA: Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 1986;103:755–766.
[PubMed]
8.
Balda MS, Anderson JM: Two classes of tight junctions are revealed by ZO-1 isoforms. Am J Physiol 1993;264:C918–C924.
[PubMed]
9.
Tsukita S, Furuse M, Itoh M: Molecular dissection of tight junctions. Cell Struct Funct 1996;21:381–385.
[PubMed]
10.
Gasbarrini G, Montalto M: Structure and function of tight junctions: Role in intestinal barrier. Ital J Gastroenterol Hepatol 1999;31:481–488.
[PubMed]
11.
Madara JL, Carlson S, Anderson JM: ZO-1 mantains its spatial distribution but dissociates from junctional fibrils during tight junction regulation. Am J Physiol 1993;264:C1096-C1101.
[PubMed]
12.
Blum MS, Toninelli E, Anderson JM, Balda MS, Zhou J, O’Donnell L, Pardi R, Bender JR: Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol 1997;273(1 Pt 2):H286–H294.
13.
Jensen-Jarolim E, Gajdzik L, Haberl I, Kraft D, Scheiner O, Graf J: Hot spices influence permeability of human intestinal epithelial monolayers. J Nutr 1998;128:577–581.
[PubMed]
14.
Gottardi CJ, Arpin M, Fanning AS, Louvard D: The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA 1996;93:10779–10784.
[PubMed]
15.
Madara JL, Stafford J, Barenberg D, Carlson S: Functional coupling of tight junctions and microfilaments in T84 monolayers. Am J Physiol 1988;254:G416–G423.
[PubMed]
16.
Itoh M, Nagafuchi A, Yonemura S, Kitani-Yasuda K, Tsukita S, Tsukita S: The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. J Cell Biol 1993;121:491–502.
[PubMed]
17.
Madara JL, Dharmsathaphorn K: Occluding junction structure-function relationships in a cultured epithelial monolayer. J Cell Biol 1985;101:2124–2133.
[PubMed]
18.
Cereijido M, Shoshani L, Contreras RG: Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity. Am J Physiol Gastrointest Liver Physiol 2000;279:G477–G482.
[PubMed]
19.
Gumbiner B: Structure, biochemistry and assembly of epithelial tight junctions. Am J Physiol 1987;253:C749–C758.
[PubMed]
20.
Nusrat A, Turner JR, Madara JL: Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: Nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000;279:G851–G857.
[PubMed]
21.
Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB: Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA 1991;88:5242–5246.
[PubMed]
22.
Smecuol E, Bai JC, Vasquez H, Kogan Z, Cabanne A, Niveloni S, Pedreira S, Boerr L, Maurino E, Meddings JB: Gastrointestinal permeability in celiac disease. Gastroenterology 1997;112:1129–1136.
[PubMed]
23.
Ma TY: Intestinal epithelial barrier dysfunction in Crohn’s disease. Proc Soc Exp Biol Med 1997;214:318–327.
[PubMed]
24.
Gardner TW, Lesher T, Khin S, Vu C, Barber AJ, Brennan WA: Histamine reduces ZO-1 tight junctional protein expression in cultured retinal microvascular endothelial cells. Biochem J 1996;320:717–721.
[PubMed]
25.
Philpott DJ, McKay DM, Sherman PM, Perdue MH: Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol 1996;270(4 Pt 1):G634–G645.
26.
Sears CL: Molecular physiology and pathophysiology of tight junctions. V. Assault of the tight junction by enteric pathogens. Am J Physiol Gastrointest Liver Physiol 2000;279:G1129–G1134.
[PubMed]
27.
Wang W, Uzzau S, Goldblum SE, Fasano A: Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 2000;113(Pt 24):4435–4440.
28.
Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE: Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000;355:1518–1519.
[PubMed]
29.
Magliocca FM, Bonamico M, Petrozza V, Correr S, Montuori M, Triglione P, Carpino F: Scanning electron microscopy of the small intestine during gluten challenge in celiac disease. Arch Histol Cytol 1992;55(suppl):125–130.
30.
Gonzalez-Mariscal L, Betanzos A, Avila-Flores A: MAGUK proteins: Structure and role in the tight junction. Semin Cell Dev Biol 2000;11:315–324.
[PubMed]
31.
Hoover KB, Liao SY, Bryant PJ: Loss of the tight junction MAGUK ZO-1 in breast cancer: Relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998;153:1767–1773.
[PubMed]
32.
Marcial MA, Carlson SL, Madara JL: Partitioning of paracellular conductance along the ileal crypt-villus axis: A hypothesis based on structural analysis with detailed consideration of tight junction structure-function relationships. J Membr Biol 1984;80:59–70.
[PubMed]
33.
Matter K, Balda MS: Biogenesis of tight junctions: The C-terminal domain of occludin mediates basolateral targeting. J Cell Sci 1998;111:511–519.
[PubMed]
34.
Moss SF, Attia L, Scholes JV, Walters JRF, Holt PR: Increased small intestinal apoptosis in coeliac disease. Gut 1996;39:811–817.
[PubMed]
35.
Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994;31:325–355.
[PubMed]
36.
Tsukita S, Itoh M, Yonemura S, Tsukita S: Submembranous junctional plaque proteins include potential tumor suppressor molecules. J Cell Biol 1993;123:1049–1053.
[PubMed]
37.
Karczewski J, Groot J: Molecular physiology and pathophysiology of tight junctions. III. Tight junction regulation by intracellular messengers: Differences in response within and between epithelia. Am J Physiol Gastrointest Liver Physiol 2000;279:G660–G665.
[PubMed]
© 2002 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2002
You do not currently have access to this content.
